Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

Brief: Eris Lifesciences Launches Generic Semaglutide Under Brand Sundae In India

March 20 (Reuters) - Eris Lifesciences Ltd ERIS.NS:

LAUNCHES GENERIC SEMAGLUTIDE UNDER BRAND SUNDAE IN INDIA

GENERIC SEMAGLUTIDE LAUNCHES IN INDIA ON MARCH 21, 2026

SUNDAE MULTI-DOSE VIALS PRICED FROM 1,290 RUPEES PER MONTH

Source text: ID:nBSE7zs6MW

Further company coverage: ERIS.NS

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Eris Lifesciences

See all news